Gemcitabine, docetaxel, and capecitabine

DRUG2 trials

Sponsors

Columbia University

Conditions

Biliary CancerPancreatic Cancer Stage IVA

Phase 2

GTX Regimen for Biliary Cancers

TerminatedNCT00868998

Columbia UniversityBiliary Cancer

Start: 2005-08-31End: 2010-10-31Updated: 2016-05-23

Study for Inoperable Non-Metastatic Pancreatic CA (Stage IVA) With Neoadjuvant GTX, and Radiation With Gemzar

CompletedNCT00869258

Columbia UniversityPancreatic Cancer Stage IVA

Start: 2005-06-30End: 2014-10-31Updated: 2016-06-22

Related Papers

Prospective phase II study of inoperable pancreatic adenocarcinoma with neoadjuvant gemcitabine, docetaxel, and capecitabine (GTX).

Journal of Clinical Oncology2014-01-203 citations